Scientists In Britain May Have Just “Accidentally” Found A Cure For Cancer

rewarding research

Scientists In Britain May Have Just “Accidentally” Found A Cure For Cancer

Profile picture for user Tyler Durdenby Tyler Durden

Every once in a while, medical researchers simply have a stroke of good luck. In this case, that “stroke of good luck” could have a profound effect on the medial community.

Researchers at Cardiff University that were in the midst of analyzing blood from a bank accidentally stumbled into an “entirely new type of T-cell”, according to The Daily WireThe new cell carries a “never before seen” type of receptor that acts like a grappling hook, latching on to most human cancers. 

Scientists Andrew Sewell and Garry Dolton of Cardiff University

Prior therapies, called CAR-T and TCR-T, which use immune cells to attach to HLA molecules on cancer cells’ surface, are incapable of fighting solid tumors, the article notes. HLA molecules vary in people, but the new therapy instead attaches to a molecule called MR1, which does not vary in humans. This gives the therapy a chance of fighting most cancers.

It also means people could share the treatment, which could allow banks of cells to be stored and offered quickly, as needed.

The treatment has already worked on lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells. The study stated:

Human leukocyte antigen (HLA)-independent, T cell-mediated targeting of cancer cells would allow immune destruction of malignancies in all individuals. Here, we use genome-wide CRISPR-Cas9 screening to establish that a T cell receptor recognized and killed most human cancer types via the monomorphic MHC class-I related protein, MR1, while remaining inert to noncancerous cells … These finding offer opportunities for HLA-independent, pan-cancer, pan-population immunotherapies.

It concluded: “In summary, we describe a TCR that exhibits pan-cancer recognition via the variant MR1 molecule, and, by equipping patients with melanoma T cells that lacked detectable cancer reactivity with the MC.7 G5 TCR, we rendered the T-cells capable of killing autologous melanoma.”

What does that mean? It means “it works”. Additionally, T-Cells of skin cancer patients altered by the treatment were capable of killing the patient’s cancer cells and other patients’ cancer cells as well.

The lead author on the study, Andrew Sewell, said: “This was a serendipitous finding, nobody knew this cell existed. Our finding raises the prospect of a ‘one-size-fits-all’ cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population. Previously nobody believed this could be possible.”

 

“This new type of T-cell therapy has enormous potential to overcome current limitations of CAR-T, which has been struggling to identify suitable and safe targets for more than a few cancer types,” said Professor Oliver Ottmann, Cardiff University’s Head of Haematology.

Trials on terminally ill patients could start as soon as November.

*********

(TLB) published this article from ZeroHedge

(TLB) added pictorial content

Related from The Liberty Beacon: LEARN 2 UNLEARN – Return To Health (E12) – Be Good To Yourself!

••••

••••

Stay tuned to …

••••

The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)

••••

Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.

••••

Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.

••••

Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.


*